LarryWonshinKwakMD

PubMed

• 1 citations
  Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3.
  Hall, J., Zhang, Z., Bhattacharya, S., Wang, D., Alcantara, M., Liang, Y., Swiderski, P., Vaidehi, N., Kortylewski, M., Forman, S., Kwak, L.> ;Molecular Therapy. Nucleic Acids. 2024 Mar 12
• 7 citations
  Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.
  Matthew Mei, Lu Chen, James Godfrey, Joo Song, Colt Egelston, Sandrine Puverel, L Elizabeth Budde, Saro Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, ...> ;Blood. 2023 Oct 19
• Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
  James Godfrey, Matthew Mei, Lu Chen, Joo Y Song, Victoria Bedell, Elizabeth Budde, Saro Armenian, Sandrine Puverel, Liana Nikolaenko, Robert Chen, Shari Daniels, Neena...> ;Haematologica. 2024 Feb 1
• 2 citations
  Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies.
  Zhenyuan Dong, Joo Y Song, Elana Thieme, Aaron Anderson, Elizabeth Oh, Wesley A Cheng, Benjamin Z Kuang, Vincent Lee, Tiantian Zhang, Zhe Wang, Szymon Szymura, D Lynne...> ;Blood Advances. 2023 Mar 28
• 2 citations
  Immortalized B Cells Transfected with mRNA of Antigen Fused to MITD (IBMAM): An Effective Tool for Antigen-Specific T-Cell Expansion and TCR Validation.
  Zhe Wang, Tiantian Zhang, Aaron Anderson, Vincent Lee, Szymon Szymura, Zhenyuan Dong, Benjamin Kuang, Elizabeth Oh, Jingwei Liu, Sattva S Neelapu, Larry Kwak, Soung-Ch...> ;Biomedicines. 2023 Mar 6
• 13 citations
  Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre,...
  Alex F Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Matthew Mei, Leslie Popplewell, Saro Armenian, Thai Cao, Leonardo Farol, Firoozeh Sahebi, Ricard...> ;The Lancet. Haematology. 2023 Jan 1
• 12 citations
  Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
  Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, Lihua Elizabeth Budde, Matthew G Mei, Tanya Siddiqi, Leslie L Popplewell, Yi-Ping Wen, Jasmine Zain,...> ;Blood. 2022 Dec 22
• 15 citations
  Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
  Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, Lihua Elizabeth Budde, Matthew G Mei, Leslie L Popplewell, Tanya Siddiqi, Jasmi...> ;Blood. 2022 Nov 10
• 35 citations
  Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
  Matthew G Mei, Hun Ju Lee, Joycelynne M Palmer, Robert Chen, Ni-Chun Tsai, Lu Chen, Kathryn McBride, D Lynne Smith, Ivana Melgar, Joo Y Song, Kimberley-Jane Bonjoc, Sa...> ;Blood. 2022 Jun 23
• 14 citations
  CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia.
  Xiuli Wang, Zhenyuan Dong, Dennis Awuah, Wen-Chung Chang, Wesley A Cheng, Vibhuti Vyas, Soung-Chul Cha, Aaron J Anderson, Tiantian Zhang, Zhe Wang, Szymon J Szymura, B...> ;Leukemia. 2022 Apr 1
• 2 citations
  Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events.
  Charles L Bennett, Krishna Gundabolu, Larry W Kwak, Benjamin Djulbegovic, Oscar Champigneulle, Brian Josephson, Linda Martin, Steven T Rosen> ;The Lancet. Haematology. 2022 Jan 1
• 6 citations
  A Randomized Phase II Trial of Idiotype Vaccination and Adoptive Autologous T-Cell Transfer in Multiple Myeloma patients.
  Muzaffar H. Qazilbash, Neeraj Saini, Cha Soung-chul, Zhe Wang, Edward A. Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal...> ;Blood. 2021 Sep 14
• 5 citations
  Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study.
  Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, Jose Angel Hernandez-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagark...> ;Blood Advances. 2021 Sep 14
• 5 citations
  Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
  Larry W. Kwak, Juan-Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Tobias F. Menne, Jose Mario Mariz, Nikolai Ilyin, Wojc...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Aug 28
• 6 citations
  Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy.
  Zhuoran Zhang, Xingli Zhao, Dongfang Wang, Dayson Moreira, Yu-Lin Su, Marice Alcantara, Piotr Swiderski, Jeffrey Y.C. Wong, Susanta K. Hui, Stephen J. Forman, Larry W....> ;Molecular Therapy. 2021 Mar 3
• 17 citations
  Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP.
  Joo Y. Song, Anamarija M. Perry, Alex F. Herrera, Lu Chen, Pam Skrabek, Michel R. Nasr, Rebecca A. Ottesen, Janet Nikowitz, Victoria Bedell, Joyce Murata-Collins, Yupi...> ;Clinical Cancer Research. 2021 Jan 7
• 22 citations
  The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma.
  Xiuli Wang, Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim, Vibhuti Vyas, Wen-Chung Chang, Brenda Aguilar, Alfonso Brito, Aniee Sarkissian, N. Achin...> ;Cancer Immunology Research. 2021 Jan 1
• 3 citations
  The changing investment in translational science by academic medical centers: HOPE in the Valley of Death.
  Lucy Ghoda, Steven T. Rosen, Larry W. Kwak> ;The Journal of Clinical Investigation. 2020 Jul 1
• 13 citations
  Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.
  Zhenyuan Dong, Wesley A. Cheng, D. Lynne Smith, Brian Huang, Tiantian Zhang, Wen-Chung Chang, Xiuli Wang, Stephen J. Forman, Larry W. Kwak, Hong Qin> ;Cancer Immunology, Immunotherapy. 2020 May 25
• 17 citations
  A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas
  Paolo Strati, Loretta J. Nastoupil, Richard E. Davis, Luis Fayad, Nathan Fowler, Fredrick B. Hagemeister, Larry W. Kwak, Yasuhiro Oki, Michael Wang, Jason R. Westin, C...> ;Haematologica. 2020 Jan 1
• Erratum: Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus M...
  Hong Qin, Pramod N. Nehete, Hong He, Bharti P. Nehete, Stephanie J. Buchl, Soung Chul Cha, Jagannadha K. Sastry, Larry W. Kwak> ;Biomed Research International. 2020 Jan 1
• 40 citations
  Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
  Robert T. Chen, Alex F. Herrera, Jessie Hou, Lu Chen, Jun Wu, Yuming Guo, Timothy W. Synold, Vu N. Ngo, Sandrine Puverel, Matthew Mei, Leslie Popplewell, Shuhua Yi, Jo...> ;Clinical Cancer Research. 2020 Mar 1
• 52 citations
  CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
  Hong Qin, Zhenyuan Dong, Xiuli Wang, Wesley A. Cheng, Feng Wen, Weili Xue, Han Sun, Miriam Walter, Guowei Wei, D. Lynne Smith, Xiuhua Sun, Fan Fei, Jianming Xie, Thean...> ;Science Translational Medicine. 2019 Sep 25
• 5 citations
  Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
  Tamer Khashab, Fredrick B. Hagemeister, Jorge E. Romaguera, Michelle A. Fanale, Barbara Pro, Peter McLaughlin, M. Alma Rodriguez, Sattva S. Neelapu, Luis Fayad, Anas Y...> ;British Journal of Haematology. 2019 May 1
• 24 citations
  Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma
  Atish Mohanty, Natalie Sandoval, An Phan, Thang Van Nguyen, Robert W. Chen, Elizabeth Budde, Matthew Mei, Leslie Popplewell, Lan V. Pham, Larry W. Kwak, Dennis D. Weis...> ;Blood. 2019 Jan 24
• Join now to see all

Journal Articles

• Long‐Term Overall‐ and Progression‐Free Survival After Pentostatin, Cyclophosphamide and Rituximab Therapy for Indolent Non‐Hodgkin Lymphoma  
  Peter McLaughlin, M Alma Rodriguez, Sattva S Neelapu, Anas Younes, Lei Feng, Michelle A Fanale, Felipe Samaniego, Barbara Pro, Luis Fayad, Fredrick Hagemeister, Jorge ..., British Journal of Haematology
• Phase I Study of an Active Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma with DNA Vaccines Encoding Antigen-Chemokine Fusion: Study Protocol  
  Sattva S Neelapu, D Lynne Smith, Vincent Y Lee, Larry W Kwak, Sheeba K Thomas, BioMed Central

Abstracts/Posters

• Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, a...
  Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• PET-Adapted Nivolumab or Nivolumab Plus ICE As First Salvage Therapy in Relapsed or Refractory Hodgkin Lymphoma
  Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in...
  Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R
  Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all